Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Equity Ratio
57.35%
Quarterly · Period ending:
LCTX Equity Ratio
Latest reported57.35%period ending
Latest reported57.35%period ending
LCTX Quarterly Equity Ratio (94.23% → 57.35%)
Latest values, visible window
High-resolution chart · PNG
LCTX equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| -25.7603% | |
| 84.6779% | |
| 78.5543% | |
| 95.0772% | |
| 89.028% | |
| 96.8563% | |
| 89.5131% | |
| 92.8571% | |
| 96.4286% | |
| 95.6989% | |
| 86.8421% | |
| 86.9565% | |
| 85.7143% | |
| 85.0746% | |
| 79.2208% | |
| 78.3133% | |
| 98.7013% | |
| 93.3333% | |
| 96% | |
| 93.3333% | |
| 96.6667% | |
| 88.8889% | |
| 97.561% | |
| 98.3051% | |
| 98.1818% | |
| 98.3051% | |
| 98.4375% | |
| 96.4286% | |
| 97.1429% | |
| 97.1429% | |
| 97.4359% | |
| 97.561% | |
| 97.7778% | |
| 95.8333% | |
| 94.2308% |